Who are Dapsone plus Tretinoin Gel's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/dapsone-plus-tretinoin-gel.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Dapsone plus Tretinoin Gel — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dapsone plus Tretinoin Gel (Dapsone plus Tretinoin Gel) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Combination topical acne agent (sulfone + retinoid). Area: Dermatology.

marketed Combination topical acne agent (sulfone + retinoid) Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

Dapsone plus Tretinoin Gel (Dapsone plus Tretinoin Gel) — Bausch Health Americas, Inc.. Dapsone reduces inflammation and bacterial growth while tretinoin promotes skin cell turnover and normalizes keratinization to treat acne and related inflammatory skin conditions.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Dapsone plus Tretinoin Gel TARGET	Dapsone plus Tretinoin Gel	Bausch Health Americas, Inc.	marketed	Combination topical acne agent (sulfone + retinoid)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Combination topical acne agent (sulfone + retinoid) class)

Bausch Health Americas, Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Dapsone plus Tretinoin Gel — Competitive Intelligence Brief. https://druglandscape.com/ci/dapsone-plus-tretinoin-gel. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab